4th Quarter - Report
BROWN RUDNICK LLP for APOTEX CORPORATION
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6310 - Food and Drug Importation Safety Act Status of ANDA #76-369 regarding calcitonin salmon nasal spray
Foreign entity interest: Apotex Holdings Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture and/or sell generic drugs and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.